Moreover, APOE4 was found to drive the downregulation of brain exosome biosynthesis and release, which plays an important role in endosomal and lysosomal deficits and could lead to a higher risk of AD development (Peng et al., 2019). Here, APOE is linked to Alzheimer disease.